Page 169 - CW E-Magazine (15-7-2025)

News from Abroad

MECHANICAL COMPLETION
WuXi XDC moves closer to starting up Singapore

bioconjugates manufacturing site

WuXi XDC Cayman Inc., the Con- stated, “The rapid mechanical comple- Singapore site will support multi-level
tract Research, Development and Manu- tion of our Singapore site marks a criti- demands ranging from small-scale
facturing Organisation (CRDMO) cal pillar in our ‘Global Dual-Sourc- clinical supplies to large-scale com-
focused on the bioconjugate industry ing’ strategy. This global site will form mercial manufacturing, including up to
and part of China’s Wuxi Biologics, a worldwide network alongside our 2,000 litres per batch of mAb/DS, and
recently announced the mechanical Wuxi, Changzhou, and Shanghai sites, 8-million vials of DP per year. These
completion of its manufacturing site at delivering end-to-end CRDMO services capabilities will ensure the efficient
Tuas Biomedical Park in Singapore. to global customers.” advancement of projects across various
stages while maintaining adherence to
This milestone signifies that this The Singapore site is expected to the highest quality standards.
manufacturing site, spanning approxi- serve as a one-stop bioconjugates manu-
mately 25,000 square meters, will now facturing centre, integrating antibody The Singapore site will operate
officially transition into the facility intermediates, drug substance (DS), complying with Good Manufacturing
C&Q (Commissioning and Qualifi- and drug products (DP). Key features Practice (GMP) regulations established
cation) stage. The Singapore site is will include state-of-the-art antibody by the US Food and Drug Administra-
expected to commence operations by intermediates production lines, bio- tion (FDA), the European Medicines
the end of 2025 and Good Manufac- conjugate DS and DP production lines, Agency (EMA), and China’s National
turing Practice (GMP) manufacturing MSAT lab, quality control, intelligent Medical Products Administration
in 2026. Upon that, the site will offer warehousing, and other utility support (NMPA). This will ensure compliance
production capabilities from the pre- areas. Equipped with cutting-edge throughout the production process,
clinical stage to commercialisation. isolator filling lines, fully automated from antibody intermediates and DS to
material transfer systems, and digital DP, enabling seamless product release
Dr. Jimmy Li, CEO of WuXi XDC, production management systems, the globally, the company said.
NUTRITION PARTNERSHIP
Brenntag to distribute Genu-In’s collagen peptides

and gelatin solutions in Asia Pacific

Germany’s Brenntag and Genu-In pines, South Korea, and Taiwan for analysis – ensures consistent perfor-
have signed a new distribution agree- premium collagen peptide and gelatin mance and formulation precision in
ment to serve Asia Pacific’s key food solutions for food and health every batch.
and health markets. applications.
The products covered under the
Genu-in, a producer of collagen With a fully integrated supply distribution agreement include colla-
peptides and gelatins, is part of JBS, a chain, Genu-in sources its primary raw gen peptides, which are known to pro-
Brazilian multinational corporation and materials – bovine hides – directly from mote skin elasticity, increase hydration,
the world’s largest producer of animal JBS’s own meat processing facilities. improve bone strength, density, and
protein. This vertical integration ensures full mass, and support joint flexibility and
traceability and consistent quality from mobility. In addition, the agreement
Under the agreement, Brenntag original cattle to final product. Genu- includes gelatin, a versatile ingre-
Nutrition will serve as the authorised in’s proprietary peptide profile tailoring dient widely used in the food industries
distributor for Genu-in in Australia, technology – combining enzymatic for its gelling, stabilising, and binding
Indonesia, Malaysia, the Philip- hydrolysis with advanced proteomic properties.

Chemical Weekly July 15, 2025 169

Contents Index to Advertisers Index to Products Advertised